Literature DB >> 15220686

Clinicopathologic characteristics of early-stage mucinous gastric carcinoma.

Kazuhiro Yasuda1, Norio Shiraishi, Masafumi Inomata, Hidefumi Shiroshita, Koichi Ishikawa, Seigo Kitano.   

Abstract

GOALS: Early mucinous gastric carcinoma (MGC) is very rare, and the clinicopathologic features are not well understood. The aim of this study is to clarify the clinicopathologic characteristics of early MGC. STUDY: A total of 806 patients with gastric cancer underwent gastrectomy between 1983 and 2002 at our department. Of these patients, 7 were found to have early MGC. MGC was defined as a tumor in which more than 50% of the tumor area contained extracellular mucin pools. Microscopic examination was performed, and particular attention was paid to the mucin component of the tumor and histologic subtype (ie, well-differentiated or poorly-differentiated).
RESULTS: The incidence of early MGC among all gastric carcinomas in our series was 0.9% (7/806). Tumors ranged in size from 1.0 cm to 7.2 cm, with a mean of 3.7 cm, and 4 appeared macroscopically elevated and 3 appeared depressed. Histologically, 3 tumors were considered well-differentiated type and 4 were considered poorly differentiated type. Microscopic features were thickening of the submucosal layer due to accumulation of abundant mucin and elevation of the surrounding normal mucosa. Tumor invaded the submucosa in 6 cases, and lymph node metastasis occurred in 1 case. However, no patient died of recurrence during follow-up periods ranging from 4 to 85 months.
CONCLUSIONS: Early MGC is characterized as an elevated lesion resembling submucosal tumor due to abundant mucin pools in the submucosa. Cases of early MGC have a good outcome similar to that of early non-MGC.

Entities:  

Mesh:

Year:  2004        PMID: 15220686     DOI: 10.1097/01.mcg.0000128991.59549.9a

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  Characteristics and prognosis of mucinous gastric carcinoma.

Authors:  Taro Isobe; Kousuke Hashimoto; Junya Kizaki; Satoru Matono; Naotaka Murakami; Tetsushi Kinugasa; Keishiro Aoyagi; Yoshito Akagi
Journal:  Mol Clin Oncol       Date:  2014-10-22

2.  Gastric lymphangioma coexisting with mucosal gastric cancer: a rare case report.

Authors:  Aika Matsushita; Norihiro Yuasa; Hideo Miyake; Hidemasa Nagai; Takuya Nagao; Masahiko Fujino
Journal:  Clin J Gastroenterol       Date:  2019-07-01

3.  Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma.

Authors:  Jae Eun Lee; Yoon Young Choi; Ji Yeong An; Ki Tae Kim; Su-Jin Shin; Jae-Ho Cheong
Journal:  Gastric Cancer       Date:  2022-05-09       Impact factor: 7.701

4.  Prognosis of early mucinous gastric carcinoma.

Authors:  Seong Yeob Ryu; Ho Gun Kim; Jae Hyuk Lee; Dong Yi Kim
Journal:  Ann Surg Treat Res       Date:  2014-06-24       Impact factor: 1.859

5.  Novel Method for Differentiating Histological Types of Gastric Adenocarcinoma by Using Confocal Raman Microspectroscopy.

Authors:  Chih-Wei Hsu; Chia-Chi Huang; Jeng-Horng Sheu; Chia-Wen Lin; Lien-Fu Lin; Jong-Shiaw Jin; Lai-Kwan Chau; Wenlung Chen
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

6.  Prognostic analysis of gastric signet ring cell carcinoma and mucinous carcinoma: a propensity score-matched study and competing risk analysis.

Authors:  Chao-Tao Tang; Youxiang Chen; Chunyan Zeng
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

7.  A Patient with Duodenal Mucinous Adenocarcinoma Presenting as a Laterally Spreading Tumor.

Authors:  Myung Joon Chae; Il Hyun Baek; Yu Mi Oh; Jun Uk Lim; Jung Won Jeon; Hyun Phil Shin; Kwang Ro Joo; Joung Il Lee
Journal:  Clin Endosc       Date:  2015-07-24

8.  Gastric Mucinous Cancer Histology: Clinicopathological Characteristics and Prognostic Value.

Authors:  Chen Jian-Hui; Cai Shi-Rong; Wu Hui; Xu Jian-Bo; Wu Kai-Ming; Chen Si-le; Yu-Long He
Journal:  Gastroenterol Res Pract       Date:  2015-12-29       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.